CrowdStrike closed September 11 at $206.74, down 0.9% on the day and 11.6% below the $233.88 52-week high, as the two-week post-earnings correction grinds sideways-to-lower inside the $204-215 range. The tape improved meaningfully on the day — fell 3.8% to 15.84 and the S&P 500 gained 0.86% — but the 10-year yield pushed higher to 4.97%, keeping sustained pressure on a 128.9x forward multiple. Technically the stock has slipped below the 20-day ($207.51), the bearish crossover is deepening (line 2.34 vs signal 3.23, histogram -0.89), has cracked the 50 line to 49.96, and has fallen to 198.7M — a full retracement of the post-earnings accumulation surge. Fundamentals remain exceptional: Q2 FY27 delivered $0.31 adjusted (+34% YoY, 6.4% beat), record net new ARR of $333M (+51%), a record $377.4M Q2 free cash flow, GAAP profitability turning positive, and a raised FY27 guide, extending a 6-for-6 beat streak. The sell-side posture is intact — zero downgrades in 90 days, a fresh raise wave (Scotiabank $250→$265, Raymond James $240→$250, Roth $200→$220, Truist at $300), and now Wedbush's initiation at Outperform naming CRWD an AI cybersecurity platform winner alongside Palo Alto — leaving the mean target of $232.69 some 12.5% above spot. The key caution flag is that the Zacks Rank has moved to #4 (Sell) with the current-fiscal-year consensus series slipping from $1.3077 to $1.2562 over the past week despite 45 upward revisions, suggesting post-print estimate normalization rather than deterioration but removing an unambiguous estimate tailwind. Insider activity remains exclusively distributive (CFO Podbere 22,000 shares, director Sullivan 5,000) with zero open-market buys. The stock sits mid-way inside the prescribed $198-212 accumulation zone with the 50-day at $199.26 as the structural floor; with earnings 80 days away and back to 15.84, the setup favors patient, half-size tranche accumulation on stabilization rather than full deployment. The single risk that must be monitored: a high-volume daily close below $194, which would surrender the 50-day , the $200 psychological level, and the entire post-earnings gap, opening a move toward the 200-day at $156.17.
投资判断
实时价格
$206.74
推荐分数
58%
58%
置信度
61%
61%
各期限展望
1个月
持有
短线
6个月
买入
中期
1年
买入
长期
核心催化
Wedbush's September 11 initiation naming CRWD an AI cybersecurity platform winner is the freshest fundamental catalyst — it extends the Scotiabank/Raymond James validation of the agentic-security theme and reinforces the consolidation narrative against Neutral-rated FTNT/QLYS/CHKP and Underperform-rated TENB. But the most consequential price-setting item remains the macro tape: with the 10-year at 4.97% and the Zacks Rank flipping to #4 on estimate normalization, the stock's near-term path is being set by rates and estimate drift, not by the accelerating business.
at 15.84 (-3.8%) has eased to the bottom of the neutral-cautious band with equities bouncing, but the 10-year at 4.97%, CRWD's 92.1% 20-day realized volatility, $11.32 (5.5% of price), a deepening bearish crossover, below 50, and distribution all argue for half normal size. The stock is already inside the prescribed accumulation zone at $206.74 — scale in only on stabilization above the 50-day ($199.26) or a high-volume reclaim of $215, not on intraday knife-catching.
投资逻辑快照
什么情况涨
CrowdStrike is executing at the highest level in its history and the correction has restored the entry discipline the prior analysis demanded: a 100% beat rate across six available quarters (surprises of +1.6% to +12%), record net new ARR of $333M growing 51%, record Q2 free cash flow of $377.4M, GAAP profitability inflection, and a raised FY27 guide with AI Detection and Response ARR nearly tripling sequentially. The agentic-security theme has converted from narrative to productized revenue via SafeMind, Falcon Guardian, and the OpenAI Codex/GPT-5.6 Cyber partnership, and the sell-side is formally ratifying it: Wedbush just initiated CRWD at Outperform as an AI cybersecurity winner, Scotiabank's 15+ customer checks confirmed 'vendor of choice' status, and zero downgrades in 90 days leave the mean target of $232.69 fully 12.5% above spot. The two-week 11.6% correction has dropped price into the $198-212 accumulation zone, cooled from 71 to 50, shrunk the extension above the 200-day from ~40% to ~32%, and 's fall to 15.84 with a broad equity bounce on September 11 suggests the macro driver of the de-rate is easing — while the primary trend (golden-cross configuration, price above /), the fortress balance sheet ($4.19B net cash), and an 80-day catalyst-free window remain fully intact. Hedge funds increased holdership from 79 to 89, and short interest at 2.41% of float leaves no squeeze fuel but also no bearish crowding.
什么情况跌
The technical damage is now real rather than cosmetic, and it is deepening, not healing: the histogram has expanded negative for a fifth straight session (-0.89), has cracked below 50 to 49.96, has fallen to 198.7M — fully retracing the post-earnings accumulation — and price has closed below the 20-day on just 0.64x average volume, meaning the drift lower is happening on apathy rather than an identifiable capitulation. The Zacks Rank has flipped to #4 (Sell) and the current-fiscal-year consensus fell from $1.3077 to $1.2562 in a week despite 45 upward revisions — the estimate tailwind that powered the run is objectively fading. At 128.9x forward earnings, a 6.68 , 39.2x sales (60-140% above FTNT and PANW per Zacks' peer math), and a 0.94% FCF yield with GAAP operating margin still at -2.26%, the stock de-rated 11.6% on macro news alone — and the trigger (10-year at 4.97% and rising) is ongoing even as eases. Wedbush's own framework notes AI spending may shift WITHIN budgets rather than expand them, Scotiabank's checks found no pull-forwards, Citadel raised put exposure 63%, and the visible insider record is exclusively distributive with zero buys. If the de-rate extends toward 100x forward, that implies roughly 22-25% downside from here, and a close below the 50-day would open the 200-day more than 24% lower. The prior $240-265 exit zone was nearly reached within days of being set — the easy money in this cycle has been made, and the marginal buyer at these multiples needs a fresh catalyst the current tape is not providing.
A daily close below $194 (surrendering the 50-day at $199.26 and the $200 psychological level by more than a full on expanding volume) would invalidate the correction-within-uptrend thesis and force an exit; fundamentally, any deceleration in net new ARR growth or the AI Detection and Response trajectory at the December 1 print — or continued 0y consensus slippage that turns estimate normalization into genuine downgrades — would break the growth-inflection thesis regardless of price action.
Valuation compression: at 128.9x forward earnings and a of 6.68, a de-rate toward 100-110x — still a premium multiple — implies roughly 22-28% downside from $206.74, and the September 1-2 sessions demonstrated the mechanism in real time with the 10-year now at 4.97% and rising.
Estimate momentum fading: the Zacks Rank moved to #4 (Sell) and the 0y consensus dropped 3.9% in one week ($1.3077→$1.2562) despite 45/0 upward revision counts — if normalization becomes genuine downgrades, the last valuation prop weakens at the worst possible time.
Technical breakdown: the deepening bearish crossover (histogram -0.89), below 50 at 49.96, distribution of -35.6M from the August 31 peak, and the failed first test of the $233.88 breakout mean a high-volume close below $200 would fill the earnings gap entirely and target the 50-day ($199.26) and below.
Demand ceiling evidence: Wedbush explicitly notes AI spending may shift within budgets rather than expand them, Scotiabank's customer checks found no budget pull-forwards despite elevated threats, SafeMind's ARR contribution is unproven, and Zacks flags competitive pricing pressure — the agentic theme may be capitalized faster than it monetizes at 39.2x sales.
Smart-money hedging and insider distribution: Citadel raised put exposure 63% to 10.98M shares while trimming calls, and the visible insider record is exclusively sell-side (CFO 22,000 shares, prior $12.7M disposition) with zero open-market buys near highs, while GAAP operating margin remains -2.26% with elevated stock-based compensation ahead of the December 1 report — 80 days away.
接下来关注
下一次财报：2026年12月1日
Wedbush's September 11 initiation naming CRWD an AI cybersecurity platform winner is the freshest fundamental catalyst — it extends the Scotiabank/Raymond James validation of the agentic-security theme and reinforces the consolidation narrative against Neutral-rated FTNT/QLYS/CHKP and Underperform-rated TENB. But the most consequential price-setting item remains the macro tape: with the 10-year at 4.97% and the Zacks Rank flipping to #4 on estimate normalization, the stock's near-term path is being set by rates and estimate drift, not by the accelerating business.
信号仪表盘
决策输入
6 个信号
基本面
12.6%
距分析师均值目标空间
At $206.74, CRWD trades at 128.9x forward earnings, 39.2x trailing sales, 41.5x book value, and a of 6.68 — an extreme multiple against 25.8% revenue growth and the ~35.5%/28.2% expected current/next-fiscal-year trajectory. The 0.94% FCF yield means the market pays roughly $212B for ~$2.0B of free cash flow, with $4.19B net cash providing just 1.98% of market cap in balance-sheet support; of 1,962x is distorted by a 1.98% trailing margin and should be ignored. The correction has widened the valuation cushion versus the sell-side: the mean target of $232.69 now sits 12.5% above spot, the median of $240 implies +16.1%, and the $119-$300 target spread shows persistent disagreement about fair value. Zacks grades CRWD an F on Value, and the peer math is stark — CRWD at roughly 31.6x forward sales versus Fortinet at 13.19x and Palo Alto at 19.16x — a ~60-140% sales-multiple premium to the security complex it is outgrowing. Zacks' proprietary framework now carries a Rank #4 (Sell) on estimate-revision dynamics even as the fundamental engine accelerates, a reminder that at this multiple the stock is priced for flawless execution. This is an elite business at an aggressive price where the margin of safety comes from the pullback entry and continued estimate momentum, not the current multiple.
技术面
Neutral
趋势质量
The primary trend remains bullish but is being tested: the $206.74 close sits below the 20-day ($207.51) for the first time since the earnings breakout, 3.8% above the rising 50-day ($199.26), and ~32.4% above the 200-day ($156.17), with the well above the (golden-cross configuration intact). The two-week sequence is a genuine correction, not a one-day wobble: from the $233.88 August 31 high, the stock broke the 20-day , probed $200.60 intraday on September 2 (closing $203.42), bounced to $214.97 on September 3, and has since made lower closes into the $204-209 area. The first test of the breakout failed, the prior $206-218 accumulation zone has been fully entered, and the structure is 'correction within uptrend' with the $200-203 gap zone and the rising 50-day as the battleground. Price remains ~32% extended above the 200-day — less stretched than before, but not yet cheap on a mean-reversion basis.
财报
80天
Accelerating
Q2 FY27 adjusted of $0.31 beat the $0.2914 consensus by 6.4% and grew 34% YoY, revenue rose 25.8% to $1.47B (a +2.15% revenue surprise), ARR reached $5.84B (+25%) on a record $333M net new ARR (+51%), GAAP net income turned positive at $5.3M, and free cash flow hit a Q2 record of $377.4M — driving the 17.9% single-day surge on August 27 before the macro-driven two-week reversal erased most of the move.
新闻
Mixed-Bullish
新闻基调
Wedbush's September 11 initiation naming CRWD an AI cybersecurity platform winner is the freshest fundamental catalyst — it extends the Scotiabank/Raymond James validation of the agentic-security theme and reinforces the consolidation narrative against Neutral-rated FTNT/QLYS/CHKP and Underperform-rated TENB. But the most consequential price-setting item remains the macro tape: with the 10-year at 4.97% and the Zacks Rank flipping to #4 on estimate normalization, the stock's near-term path is being set by rates and estimate drift, not by the accelerating business.
宏观
Neutral
4.97% 10Y / 15.8 VIX
has eased to 15.84 with equities bouncing (S&P +0.86%) — a modest risk-appetite recovery at the bottom of the cautious band — but the 10-year yield at 4.97% and still rising keeps a rising-rate floor under discount rates that mechanically compresses CRWD's 128.9x forward multiple and 39.2x sales regardless of accelerating fundamentals.
稳定性
High-Beta Growth
Satellite Upside
CrowdStrike pairs elite software economics (75.19% gross margin, +25.8% revenue growth, $4.19B net cash, a 100% beat rate across six available quarters, and record Q2 free cash flow) with an extreme valuation of 128.9x forward earnings, a 6.68 , 39.2x sales, and a 0.94% FCF yield. The past two weeks have shown both sides of that bargain: a 11.6% peak-to-trough slide from $233.88 to the $200.60 September 2 low, followed by stabilization in the $204-215 range with the still in a bearish crossover and bleeding to 198.7M. The franchise and the agentic-AI security engine (OpenAI partnership, SafeMind, Falcon Guardian, and now Wedbush naming CRWD an AI cybersecurity winner at initiation) are durable, but the multiple remains hostage to a 10-year yield at 4.97% and 92.1% 20-day realized volatility. This belongs as a satellite upside position in aggressive growth sleeves, accumulated on weakness near the 50-day rather than chased into strength.
分析师目标区间
均值目标
$232.69
高低目标
$119 / $300
分析师中值目标
$240.00
共识区间
$119 - $300
— 位分析师
Mean
$119$233$300
市场共识
The posture is overwhelmingly bullish: 10 Strong Buy, 29 Buy, 12 Hold, 0 Sell, 1 Strong Sell, with zero downgrades in 90 days and a fresh raise wave extending to Scotiabank's $265 and Truist's $300, now joined by Wedbush's initiating Outperform that names CRWD an AI cybersecurity winner. The correction has widened the consensus cushion: the mean target of $232.69 sits 12.5% above the $206.74 market price, and the median of $240 implies +16.1%. The $119-$300 spread signals extreme disagreement, and the 12 Holds (including Macquarie's Neutral at $200 — now slightly above spot) reflect genuine concern over SBC, decelerating-from-hypergrowth revenue, and pricing competition. With consensus well above spot, continued raise cadence becomes upside optionality rather than a required prop.
筹码脉冲
内部人信号
Moderate Sell
净偏向
Sell-heavy
内部人持股
1.4%
机构持股
76.4%
解读
The totality of insider activity is sell-heavy with no buying confirmation — a caution flag near highs — though the pattern (CFO and director dispositions without dollar disclosure, no cluster selling by multiple C-suite officers) is most consistent with routine 10b5-1-style diversification rather than a discretionary loss of confidence, and founder-level selling alone does not justify a bearish long-term view.
重要活动
The current bundle shows two filings: CFO Burt Podbere disposed of 22,000 shares (direct ownership) and Director Godfrey Sullivan reported 5,000 shares (indirect); dollar values are not provided in this bundle. Combined with the prior window's ~$12.7M disposition by President Michael Sentonas, the visible insider record remains exclusively distributional with zero open-market purchases while the stock sits ~141% above its 52-week low.
市场背景
行业
Software - Infrastructure
Neutral
情绪
10
跟踪股票
10
分组
industry
Software - Infrastructure 行业 当前情绪为 Neutral，板块平均评分约 56 分，整体偏稳，且leadership is concentrated in MSFT, ORCL, PLTR。
Enterprise AI agents are creating a new attack surface — rogue agents stealing data, altering permissions, and controlling systems at runtime — and security budgets are responding. CrowdStrike has now productized the theme three ways: SafeMind threat-detection models on NVIDIA Nemotron, Falcon Guardian runtime protection for AI agents on endpoints, and the OpenAI partnership to secure Codex agents with GPT-5.6 Cyber integrated into Falcon. Wedbush's September 11 initiation — Outperform on CRWD, PANW, and RBRK as the AI cybersecurity winners, versus Neutral ratings for FTNT, QLYS, and CHKP and Underperform for TENB — extends the Scotiabank 'vendor of choice' validation and confirms sell-side capital is concentrating on agentic-security platform leaders. AI Detection and Response ARR nearly tripled sequentially with 400% growth in Claude usage. The theme is strengthening, but the same channel checks found customers are NOT pulling budgets forward — at 39.2x sales, much of the acceleration is already capitalized.
Wedbush's September 11 initiation of coverage across the security complex explicitly framed AI-based attacks and defenses plus vendor consolidation as the spending shifts that favor CRWD and PANW, days after the OpenAI partnership and Fal.Con product launches.
Wedbush's differentiated ratings map capital to the theme leaders — Outperform for CRWD/PANW/RBRK/DDOG versus Neutral for FTNT/QLYS/CHKP and Underperform for TENB — a formal sell-side ranking of agentic-security winners and losers
CRWD AI Detection and Response ARR nearly tripled quarter-over-quarter with 400% growth in Claude usage, and the OpenAI Codex/GPT-5.6 Cyber partnership converts the theme into productized, third-party-validated revenue; Fortinet's Virtue AI acquisition for agentic red-teaming shows M&A consolidating around the same narrative
Cybersecurity Consolidation and High-Multiple Software De-Rating
评分: 55
Mixed-Bullish
Capital remains concentrated in the security platform complex, but the theme is at a decision point: the Zacks Security industry lost 7.8% over the past month and CRWD is down 7.4%, showing that a rising-rate tape (10-year at 4.97%) can pause the entire high-multiple software bid simultaneously. Wedbush's initiation crystallizes the consolidation bifurcation — platform winners (CRWD, PANW) versus Neutral-rated point-product vendors (FTNT, QLYS, CHKP) and Underperform-rated TENB — while Zscaler's prior downgrade-to-exit call illustrated the same dispersion. CRWD sits at the center of both consolidation and the agentic-AI re-rating with 51% of subscription customers on six or more modules, but its 39.2x sales multiple is the most extended in its peer set, making it the highest-beta expression of the theme in a rising-rate regime.
Wedbush's September 11 initiation formalized the platform-versus-point-product bifurcation at the same moment the 10-year yield pushed to 4.97% and the Zacks Rank for CRWD flipped to #4 (Sell) on estimate normalization — a direct collision between thematic strength and multiple compression.
Security-industry dispersion: Wedbush's Outperform ratings for CRWD/PANW versus Neutral for FTNT/QLYS/CHKP and Underperform for TENB formalize capital concentration in platform consolidators even as the whole industry fell 7.8% over the past month
Rising 10-year yields (4.80%→4.97%) are stress-testing the durability of the entire high-multiple software bid, with CRWD down 11.6% from its 52-week high as the de-rating plays out — though 's fall to 15.84 with a 0.86% S&P bounce on September 11 hints the pressure may be easing
关键指标
23 项指标
市值
$211.69B
市盈率 (TTM)
5168.5
远期市盈率
128.9
营收增速
25.8%
净资产收益率
1.5%
Beta 系数
1.25
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
39.2
市净率
41.5
企业价值 / EBITDA
1962.4
质量与资产负债表
利润率、杠杆与流动性。
毛利率
75.2%
营业利润率
-2.3%
资产负债率
16.0
流动比率
1.57x
速动比率
1.37x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
2.4%
空头回补天数
2.59x
52周最高
$233.88
52周最低
$85.68
距52周高点
-11.6%
距52周低点
141.3%
公司分类
板块与行业背景。
板块
Technology
行业
Software - Infrastructure
其他信号
自由现金流
$1995385472.00
详细分析
估值
At $206.74, CRWD trades at 128.9x forward earnings, 39.2x trailing sales, 41.5x book value, and a of 6.68 — an extreme multiple against 25.8% revenue growth and the ~35.5%/28.2% expected current/next-fiscal-year trajectory. The 0.94% FCF yield means the market pays roughly $212B for ~$2.0B of free cash flow, with $4.19B net cash providing just 1.98% of market cap in balance-sheet support; of 1,962x is distorted by a 1.98% trailing margin and should be ignored. The correction has widened the valuation cushion versus the sell-side: the mean target of $232.69 now sits 12.5% above spot, the median of $240 implies +16.1%, and the $119-$300 target spread shows persistent disagreement about fair value. Zacks grades CRWD an F on Value, and the peer math is stark — CRWD at roughly 31.6x forward sales versus Fortinet at 13.19x and Palo Alto at 19.16x — a ~60-140% sales-multiple premium to the security complex it is outgrowing. Zacks' proprietary framework now carries a Rank #4 (Sell) on estimate-revision dynamics even as the fundamental engine accelerates, a reminder that at this multiple the stock is priced for flawless execution. This is an elite business at an aggressive price where the margin of safety comes from the pullback entry and continued estimate momentum, not the current multiple.
资产负债表
Fortress-grade and unchanged: $5.01B total cash against $0.82B total debt, net cash of $4.19B, cash-to-debt of 6.11x, debt-to-equity of just 16%, operating cash flow of $2.02B covering debt 2.46x, and a Q2 record $377.4M in free cash flow on $530.3M operating cash flow. The current ratio (1.57) and quick ratio (1.37) confirm healthy short-term solvency. This balance sheet gives management full capacity for AI-security investment and M&A with zero dilution risk — critical optionality if the macro tape forces a sector-wide valuation reset.
增长
Revenue growth of 25.8% YoY with record net new ARR of $333M (+51% YoY) and total ARR of $5.84B (+25%), with a raised FY27 outlook embedding ~34% net new ARR growth at the midpoint. Consensus models $5.99B FY revenue (+24.5%) and $7.33B next year (+22.3%), with current-quarter of $0.31 implying +29.2% YoY. Multi-product expansion remains broad-based: AI Detection and Response ARR nearly tripled sequentially with 400% growth in Claude usage, identity ARR rose 34% to more than $585M, Falcon Shield ARR surged more than 185%, and 51% of subscription customers now run six or more Falcon modules. One honest caveat: the consensus 0y series has slipped from $1.3077 to $1.2562 and +1y from $1.6548 to $1.6045 over the past week even as revision counts print 45 up/0 down on the year — most plausibly fiscal-period and post-print normalization (Zacks frames it as -61%/-87% 30-day consensus changes), but it tempers the 'estimates only go up' narrative.
生意质量
Gross margin of 75.19% reflects elite software economics, and the Q2 GAAP profitability inflection ($5.3M net income, 0.83% net margin) is a genuine milestone. Operating margin (-2.26%) and margin (1.98%) remain roughly breakeven on a GAAP basis with at -0.78% and at just 1.46% due to heavy growth investment — the ~$212B valuation still rests predominantly on future profitability, not current GAAP earnings power. Free cash flow conversion is real and expanding ($377.4M record in Q2, $2.0B trailing). Institutional ownership of 76.4% confirms a high-quality holder base; hedge fund holders rose from 79 to 89 in the prior quarter (DE Shaw added 18% to 8.53M shares), though Citadel's simultaneous 63% increase in put positions (10.98M put shares vs 10.46M call shares) shows sophisticated money actively hedging. Short interest remains modest at 2.41% of float (short ratio 2.59) — no bearish crowding.
资本配置
Management is prioritizing R&D and platform expansion (SafeMind, Falcon Guardian, Charlotte Agentic SOAR, the OpenAI and Rubrik integrations) and with $5.01B cash versus $0.82B debt can invest without dilutive financing. Share count (~1.02B) is stable, no buyback is evident, and the raised FY27 guide signals confidence in reinvestment ROI. Capital deployment is creating value through growth investment rather than returning cash — appropriate at this stage, but it leaves shareholders fully exposed to multiple-compression risk, which the last two weeks demonstrated at scale.
预期修正
The revision picture is strong on breadth but mixed on level: 0y revisions printed 45 up/0 down over both 7 and 30 days and +1y printed 40 up versus 3 down over 30 days — an overwhelmingly positive posture — while near-term series are also net positive (+1q: 25 up/10 down over 30 days; 0q: 13 up/11 down over 30 days). However, the actual consensus values ticked down over the past week (0y $1.3077→$1.2562; +1y $1.6548→$1.6045), which most plausibly reflects post-print coverage normalization and fiscal-period rotation rather than genuine downgrades — but it is precisely this dynamic that pushed the Zacks Rank to #4 (Sell), and it means the estimate tailwind is no longer unambiguous. The sell-side remains in target-raise mode (Raymond James $240→$250, Scotiabank $250→$265, Roth $200→$220, Truist at $300) with zero downgrades in 90 days and only one Strong Sell across 52 rated analysts.